Article History
Received: 5 August 2024
Accepted: 1 September 2024
First Online: 2 October 2024
Declarations
:
: KE has been member on advisory boards for Eli Lilly & Co., NovoNordisk, Lifescan, Roche, GSK, Bayer and has received honoraria from these activities; LDN has participated in the advisory boards for AstraZeneca and Bayer and has received honoraria for this activity; DG has no conflicts of interest to declare.
: Not applicable (no original data).
: Not applicable (no original data).